Two Sigma Investments’s BioLife Solutions BLFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-15,800
Closed -$403K 4082
2025
Q3
$403K Buy
+15,800
New +$375K ﹤0.01% 3087
2023
Q3
Sell
-27,000
Closed -$597K 2961
2023
Q2
$597K Sell
27,000
-7,200
-21% -$152K ﹤0.01% 2248
2023
Q1
$744K Buy
34,200
+21,900
+178% +$493K ﹤0.01% 2025
2022
Q4
$224K Buy
+12,300
New +$254K ﹤0.01% 2355
2022
Q2
Sell
-108,459
Closed -$2.46M 2529
2022
Q1
$2.46M Buy
+108,459
New +$2.86M 0.01% 1253
2021
Q3
Sell
-7,900
Closed -$352K 4242
2021
Q2
$352K Sell
7,900
-113,510
-93% -$4M ﹤0.01% 3374
2021
Q1
$4.37M Buy
121,410
+92,310
+317% +$3.65M 0.01% 1145
2020
Q4
$1.16M Buy
+29,100
New +$992K ﹤0.01% 1880
2020
Q3
Sell
-41,687
Closed -$682K 3090
2020
Q2
$682K Buy
+41,687
New +$575K ﹤0.01% 1782
2019
Q1
Sell
-62,468
Closed -$751K 3024
2018
Q4
$751K Sell
62,468
-43,369
-41% -$518K ﹤0.01% 1833
2018
Q3
$1.85M Buy
105,837
+81,842
+341% +$1.62M 0.01% 1531
2018
Q2
$274K Buy
23,995
+6,838
+40% +$62.3K ﹤0.01% 2995
2018
Q1
$88K Buy
17,157
+757
+5% +$4.1K ﹤0.01% 3047
2017
Q4
$98K Buy
+16,400
New +$94.5K ﹤0.01% 2995

Other funds holding BLFS

Two Sigma Investments's BLFS Position: Q4 2025 in Review

Two Sigma Investments sold out of BioLife Solutions (BLFS) in Q4 2025, closing a stake of 15,800 shares — an estimated $403K sold.

Two Sigma Investments first reported a position in BLFS in Q4 2017 and held it in 14 quarters. The position peaked at $4.37M in Q1 2021. 187 funds tracked by Wall St. Rank hold BLFS as of Q4 2025.

  • Two Sigma Investments reported no remaining BioLife Solutions position as of Q4 2025 after selling out during the quarter.
  • Two Sigma Investments sold 15,800 BioLife Solutions shares in Q4 2025, an estimated $403K.
  • Two Sigma Investments first reported a position in BioLife Solutions in Q4 2017 and held it in 14 quarters.
  • Two Sigma Investments's BioLife Solutions position peaked at $4.37M in Q1 2021.
  • 187 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2025.

Based on Two Sigma Investments's 13F filing for Q4 2025, filed 17 Feb 2026.